77 related articles for article (PubMed ID: 16999721)
1. The relation between plasminogen activator inhibitor activity and disease activation in acute myeloblastic leukaemia patients.
Yilmaz M; Dagdas S; Aki SZ; Guler N; Akoz AG; Erdin Z; Alanoglu G; Ozet G
Clin Lab Haematol; 2006 Oct; 28(5):313-6. PubMed ID: 16999721
[TBL] [Abstract][Full Text] [Related]
2. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
3. [The significance of plasminogen activator inhibitor 2 in patients with hematologic malignancies].
Cetkovský P; Koza V; Cepelák V; Vít L
Vnitr Lek; 1993 Sep; 39(9):871-5. PubMed ID: 8212641
[TBL] [Abstract][Full Text] [Related]
4. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
5. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
[TBL] [Abstract][Full Text] [Related]
6. [Study of fibrinolysis inhibitors in 117 acute leukemia patients].
Wang W; Ji CY; Ye JJ; Zhu YY; Guo DM; Ji M
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):183-6. PubMed ID: 18788619
[TBL] [Abstract][Full Text] [Related]
7. Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis.
Offersen BV; Pfeiffer P; Andreasen P; Overgaard J
Lung Cancer; 2007 Apr; 56(1):43-50. PubMed ID: 17207889
[TBL] [Abstract][Full Text] [Related]
8. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation.
Katsaros KM; Kastl SP; Huber K; Zorn G; Maurer G; Glogar D; Wojta J; Christ G; Speidl WS
Thromb Res; 2008; 123(1):79-84. PubMed ID: 18558425
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of plasminogen activator in neutrophils and mononuclear cells from septic patients.
Haj MA; Robbie LA; Adey GD; Bennett B
Thromb Haemost; 1995 Dec; 74(6):1528-32. PubMed ID: 8772232
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients.
De Cremoux P; Grandin L; Diéras V; Savignoni A; Degeorges A; Salmon R; Bollet MA; Reyal F; Sigal-Zafrani B; Vincent-Salomon A; Sastre-Garau X; Magdelénat H; Mignot L; Fourquet A;
Anticancer Res; 2009 May; 29(5):1475-82. PubMed ID: 19443353
[TBL] [Abstract][Full Text] [Related]
12. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia.
Wikström AK; Nash P; Eriksson UJ; Olovsson MH
Am J Obstet Gynecol; 2009 Dec; 201(6):597.e1-8. PubMed ID: 19683696
[TBL] [Abstract][Full Text] [Related]
13. Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer.
Steiner E; Pollow K; Hasenclever D; Schormann W; Hermes M; Schmidt M; Puhl A; Brulport M; Bauer A; Petry IB; Koelbl H; Hengstler JG
Gynecol Oncol; 2008 Mar; 108(3):569-76. PubMed ID: 18222533
[TBL] [Abstract][Full Text] [Related]
14. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass.
Pretorius M; Donahue BS; Yu C; Greelish JP; Roden DM; Brown NJ
Circulation; 2007 Sep; 116(11 Suppl):I1-7. PubMed ID: 17846288
[TBL] [Abstract][Full Text] [Related]
16. [Serine protease inhibitors in plasma of patients with ulcerative colitis].
Swiatkowski M; Pulkowski G; Kłopocka M; Budzyński J; Wiśniewsk E; Kotschy M
Przegl Lek; 2001; 58(2):67-70. PubMed ID: 11475845
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer.
Palmirotta R; Ferroni P; Savonarola A; Martini F; Ciatti F; Laudisi A; Sini V; Del Monte G; Guadagni F; Roselli M
Thromb Res; 2009 Sep; 124(4):403-8. PubMed ID: 19351570
[TBL] [Abstract][Full Text] [Related]
18. The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy.
Naruse K; Lash GE; Bulmer JN; Innes BA; Otun HA; Searle RF; Robson SC
Placenta; 2009 May; 30(5):398-404. PubMed ID: 19272641
[TBL] [Abstract][Full Text] [Related]
19. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
20. High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomas.
Iwadate Y; Hayama M; Adachi A; Matsutani T; Nagai Y; Hiwasa T; Saeki N
Anticancer Res; 2008; 28(1B):415-8. PubMed ID: 18383878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
